Advertisement

Topics

Brickell Biotech Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25072017] Prices from USD $250

19:04 EDT 22 Aug 2017 | BioPortfolio Reports

Summary

Brickell Biotech Inc Brickell Biotech is a clinicalstage therapeutics development company that offers treatment of skin diseases. The company offers product candidates such as bbi4000, bbi5000, bbi2000, bbi3000 and bbi6000. Its product candidate bbi4000 an anticholinergic in Phase IIb clinical trials for the treatment of primary axillary hyperhidrosis; bbi5000, a selective oral immunomodulator in phase I clinical trials for moderate to severe atopic dermatitis. Brickell Biotech's bbi2000, an antiinflammatory peptide in preclinical stage for contact dermatitis, and bbi3000, a potent topical and oral retinoid in preclinical stage for the treatment of acne. The company serves hyperhidrosis, atopic dermatitis, contact dermatitis, acne, and psoriasis. It operates through cosmetic and aesthetics companies, pharmaceutical and healthcare companies. Brickell Biotech is headquartered in Boulder, Colorado, the US.

Brickell Biotech Inc Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions.

GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector.
Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios.
Business Description A brief description of the company's operations.
Key Employees A list of the key executives of the company.
Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors A list of the key competitors of the company.
Key Recent Developments A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay uptodate on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Original Article: Brickell Biotech Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25072017] Prices from USD $250

NEXT ARTICLE

More From BioPortfolio on "Brickell Biotech Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25072017] Prices from USD $250"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...